Literature DB >> 17643065

Plants as alternative systems for production of vaccines.

Jessica A Chichester1, Vidadi Yusibov.   

Abstract

Subunit vaccine production is typically associated with bacterial, yeast, insect or mammalian cell culture systems. Plants, however, are emerging as an alternative platform for producing vaccine antigens, and offer some advantages over other recombinant systems. In particular, plant virus-based transient expression systems are suitable for rapid engineering, ease of scale-up and cost-effective production of target antigens. In addition, this system provides an ideal approach for producing large quantities of vaccine antigens in a short period of time, which is particularly important when faced with natural outbreaks or accidental or intended release of bio-threat agents such as Bacillus anthrax and Yersinia pestis. This commentary reviews the production and evaluation of antigens made in plants in an attempt to develop vaccines against B. anthracis and Y. pestis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643065     DOI: 10.4161/hv.3.4.4148

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  10 in total

1.  A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.

Authors:  Yoko Shoji; R Mark Jones; Vadim Mett; Jessica A Chichester; Konstantin Musiychuk; Xiangjie Sun; Terrence M Tumpey; Brian J Green; Moneim Shamloul; Joey Norikane; Hong Bi; Caitlin E Hartman; Cory Bottone; Michelle Stewart; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

2.  A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.

Authors:  Jessica A Chichester; Slobodanka D Manceva; Amy Rhee; Megan V Coffin; Konstantin Musiychuk; Vadim Mett; Moneim Shamloul; Joey Norikane; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

3.  Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.

Authors:  Yoko Shoji; Alex Prokhnevsky; Brett Leffet; Nancy Vetter; Stephen Tottey; Shama Satinover; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; R Mark Jones; Jessica A Chichester; Brian J Green; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin.

Authors:  Eugenia S Mardanova; Roman Y Kotlyarov; Victor V Kuprianov; Liudmila A Stepanova; Liudmila M Tsybalova; George P Lomonossoff; Nikolai V Ravin
Journal:  Bioengineered       Date:  2015-12-28       Impact factor: 3.269

5.  The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

Authors:  Åsne Jul-Larsen; Abdullah S Madhun; Karl A Brokstad; Emanuele Montomoli; Vidadi Yusibov; Rebecca J Cox
Journal:  Hum Vaccin Immunother       Date:  2012-05-01       Impact factor: 3.452

6.  Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique.

Authors:  Vanessa Neuhaus; Katharina Schwarz; Anna Klee; Sophie Seehase; Christine Förster; Olaf Pfennig; Danny Jonigk; Hans-Gerd Fieguth; Wolfgang Koch; Gregor Warnecke; Vidadi Yusibov; Katherina Sewald; Armin Braun
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

7.  Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.

Authors:  Christopher A Seid; Elena Curti; R Mark Jones; Elissa Hudspeth; Wanderson Rezende; Jeroen Pollet; Lori Center; Leroy Versteeg; Sonya Pritchard; Konstantin Musiychuk; Vidadi Yusibov; Peter J Hotez; Maria Elena Bottazzi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.

Authors:  Diane Major; Jessica A Chichester; Rishi D Pathirana; Kate Guilfoyle; Yoko Shoji; Carlos A Guzman; Vidadi Yusibov; Rebecca J Cox
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.

Authors:  Eugenia S Mardanova; Roman Y Kotlyarov; Victor V Kuprianov; Liudmila A Stepanova; Liudmila M Tsybalova; George P Lomonosoff; Nikolai V Ravin
Journal:  BMC Biotechnol       Date:  2015-05-29       Impact factor: 2.563

10.  A plant-based system for rapid production of influenza vaccine antigens.

Authors:  Yoko Shoji; Christine E Farrance; James Bautista; Hong Bi; Konstantin Musiychuk; April Horsey; Heewoo Park; Jennifer Jaje; Brian J Green; Moneim Shamloul; Satish Sharma; Jessica A Chichester; Vadim Mett; Vidadi Yusibov
Journal:  Influenza Other Respir Viruses       Date:  2011-10-04       Impact factor: 4.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.